Listen
CONTRAMAL (tramadol) - Treatment of acute pain
Opinions on drugs -
Posted on
Dec 12 2024
Reason for request
First listing
Summary of opinion
Favourable opinion for reimbursement in the following indications:
- CONTRAMAL 50 mg hard capsules: “Treatment of moderate to severe pain in adults” (adults and adolescents over 15 years of age)
- CONTRAMAL LP 100 mg, 150 mg and 200 mg prolonged-release tablets: “Treatment of moderate to severe pain in adults” (adults and adolescents over 12 years of age)
No clinical added value of the new forms in non-pre-cut blister strips compared to the forms already available in individual pre-cut heat-formed blister strips.
Clinical Benefit
| Substantial |
The Committee considers that the clinical benefit of CONTRAMAL 50 mg hard capsules, and CONTRAMAL LP 100 mg, 150 mg and 200 mg prolonged-release tablets is substantial in the MA indication.
|
Clinical Added Value
| no clinical added value |
These medicinal products are a range supplement that do not provide any clinical added value (CAV V) compared to the forms already listed. |
Documents
English version
Contact Us
Évaluation des médicaments
